Polynucleotide viral vaccines: codon optimisation and ubiquitin conjugation enhances prophylactic and therapeutic efficacy. (Q43514345)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11738751%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

title

Polynucleotide viral vaccines: codon optimisation and ubiquitin conjugation enhances prophylactic and therapeutic efficacy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11738751%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11738751%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

Ian Frazer

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11738751%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

author name string

W J Liu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11738751%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

K N Zhao

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11738751%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

F G Gao

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11738751%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

G J Fernando

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11738751%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

language of work or name

English

0 references

publication date

1 December 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11738751%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

number of pages

8

1 reference

inferred from page(s)

published in

Vaccine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11738751%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11738751%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

issue

5-6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11738751%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

page(s)

862-869

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11738751%20AND%20SRC:MED&resulttype=core&format=json

Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer

4 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900406-6

7 January 2021

Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900406-6

7 January 2021

Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900406-6

7 January 2021

Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900406-6

7 January 2021

Antibodies against linear and conformational epitopes of human papillomavirus type 16 that independently associate with incident cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900406-6

7 January 2021

A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900406-6

7 January 2021

Potential strategies utilised by papillomavirus to evade host immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900406-6

7 January 2021

DNA vaccination prevents and/or delays carcinoma development of papillomavirus-induced skin papillomas on rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900406-6

7 January 2021

Rabbit oral papillomavirus complete genome sequence and immunity following genital infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900406-6

7 January 2021

HPV6b virus like particles are potent immunogens without adjuvant in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900406-6

7 January 2021

Relative potency of cellular and humoral immune responses induced by DNA vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900406-6

7 January 2021

Codon optimization effect on translational efficiency of DNA vaccine in mammalian cells: analysis of plasmid DNA encoding a CTL epitope derived from microorganisms.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900406-6

7 January 2021

Nasal immunization of mice with human papillomavirus type 16 (HPV-16) virus-like particles or with the HPV-16 L1 gene elicits specific cytotoxic T lymphocytes in vaginal draining lymph nodes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900406-6

7 January 2021

Induction of an HPV 6bL1-specific mucosal IgA response by DNA immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900406-6

7 January 2021

Prospects for human papillomavirus vaccine development: emerging HPV vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900406-6

7 January 2021

A vaccine conjugate of 'ISCAR' immunocarrier and peptide epitopes of the E7 cervical cancer-associated protein of human papillomavirus type 16 elicits specific Th1- and Th2-type responses in immunized mice in the absence of oil-based adjuvants.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900406-6

7 January 2021

Papillomavirus virus-like particles can deliver defined CTL epitopes to the MHC class I pathway.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900406-6

7 January 2021

Structural polypeptides of rabbit, bovine, and human papillomaviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900406-6

7 January 2021

The human papillomavirus E7 oncoprotein abrogates signaling mediated by interferon-alpha.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900406-6

7 January 2021

Quantification of antigen specific CD8+ T cells using an ELISPOT assay.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900406-6

7 January 2021

Identification of the nuclear localization signal of human papillomavirus type 16 L1 protein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900406-6

7 January 2021

Chimeric papillomavirus-like particles

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900406-6

7 January 2021

Increased expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 gag gene

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900406-6

7 January 2021

Increased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usage

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900406-6

7 January 2021

Codon usage limitation in the expression of HIV-1 envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900406-6

7 January 2021

Biological features of genetic immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900406-6

7 January 2021

Protection against papillomavirus with a polynucleotide vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900406-6

7 January 2021

Particle-mediated delivery of recombinant expression vectors to rabbit skin induces high-titered polyclonal antisera (and circumvents purification of a protein immunogen).

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900406-6

7 January 2021

Human papillomavirus vaccines for cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900406-6

7 January 2021

A recombinant human papillomavirus (HPV) type 16 L1-vaccinia virus murine challenge model demonstrates cell-mediated immunity against HPV virus-like particles

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900406-6

7 January 2021

L1-specific protection from tumor challenge elicited by HPV16 virus-like particles

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900406-6

7 January 2021

A role for the ubiquitin-dependent proteolytic pathway in MHC class I-restricted antigen presentation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900406-6

7 January 2021

An autologous oral DNA vaccine protects against murine melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900406-6

7 January 2021

Targeting of HIV-1 antigens for rapid intracellular degradation enhances cytotoxic T lymphocyte (CTL) recognition and the induction of de novo CTL responses in vivo after immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900406-6

7 January 2021

DNA immunization targeting the skin: molecular control of adaptive immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900406-6

7 January 2021

Induction of MHC class I-restricted CTL response by DNA immunization with ubiquitin-influenza virus nucleoprotein fusion antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900406-6

7 January 2021